logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

KINGDEE INT'L (00268) spent 9 million Hong Kong dollars to repurchase 1 million shares on March 26th.

date
17:21 26/03/2026
avatar
GMT Eight
Kingdee International (00268) announced that on March 26, 2026, it spent HK$9 million to repurchase 1 million shares.
KINGDEE INT'L (00268) announced on March 26, 2026 that it will spend 9 million Hong Kong dollars to buy back 1 million shares.
Related Articles
HK Stock
On March 26, AK MEDICAL (01789) spent HKD 7.1879 million to repurchase 1.194 million shares.
HK Stock
LIVZON PHARMA (01513): Received Drug Clinical Trial Approval Notice for Injectable Brivaracetam Microspheres
HK Stock
Liaoning Port (02880) releases annual performance with a net profit attributable to equity holders of 1.307 billion yuan, an increase of 14.23% year-on-year.
On March 26, AK MEDICAL (01789) spent HKD 7.1879 million to repurchase 1.194 million shares.
HK Stock
LIVZON PHARMA (01513): Received Drug Clinical Trial Approval Notice for Injectable Brivaracetam Microspheres
HK Stock
Liaoning Port (02880) releases annual performance with a net profit attributable to equity holders of 1.307 billion yuan, an increase of 14.23% year-on-year.
HK Stock
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
icon
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
icon
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
icon
26/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.